| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.1 | $5k-$25k | 0.00 |
Summary
A vulnerability identified as very critical has been detected in Oracle Hyperion BI+ 11.1.2.2/11.1.2.3. The impacted element is an unknown function of the component Reporting/Analysis. Performing a manipulation results in an unknown weakness. This vulnerability is known as CVE-2015-0509. No exploit is available. You should upgrade the affected component.
Details
A vulnerability was found in Oracle Hyperion BI+ 11.1.2.2/11.1.2.3. It has been classified as critical. This affects some unknown functionality of the component Reporting/Analysis. This is going to have an impact on integrity. The summary by CVE is:
Unspecified vulnerability in the Oracle Hyperion BI+ component in Oracle Hyperion 11.1.2.2 and 11.1.2.3 allows remote attackers to affect integrity via unknown vectors related to Reporting and Analysis.
The weakness was published 04/14/2015 with Oracle as Oracle Critical Patch Update Advisory - April 2015 as confirmed advisory (Website). It is possible to read the advisory at oracle.com. This vulnerability is uniquely identified as CVE-2015-0509 since 12/17/2014. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 05/06/2022).
We expect the 0-day to have been worth approximately $25k-$100k.
Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at SecurityFocus (BID 74074†) and Vulnerability Center (SBV-49725†). Further details are available at krebsonsecurity.com. Similar entries are available at VDB-74910, VDB-74899, VDB-74900 and VDB-74901. Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.1
VulDB Base Score: 5.3
VulDB Temp Score: 5.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: UnknownCWE: Unknown
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Timeline
12/17/2014 🔍04/14/2015 🔍
04/14/2015 🔍
04/14/2015 🔍
04/14/2015 🔍
04/15/2015 🔍
04/16/2015 🔍
04/16/2015 🔍
05/06/2022 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - April 2015
Organization: Oracle
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2015-0509 (🔍)
GCVE (CVE): GCVE-0-2015-0509
GCVE (VulDB): GCVE-100-74895
SecurityFocus: 74074 - Oracle Hyperion BI+ CVE-2015-0509 Remote Security Vulnerability
SecurityTracker: 1032123
Vulnerability Center: 49725 - [cpuapr2015-2365600] Oracle Hyperion BI+ Remote DB Write Vulnerability in Reporting and Analysis, Medium
Misc.: 🔍
See also: 🔍
Entry
Created: 04/15/2015 14:26Updated: 05/06/2022 14:40
Changes: 04/15/2015 14:26 (61), 06/26/2017 10:43 (3), 05/06/2022 14:40 (3)
Complete: 🔍
Cache ID: 216:E70:103
No comments yet. Languages: en.
Please log in to comment.